Tropea

Cameron Tropea, Gross-Umstadt DE

Patent application number	Description	Published
20140268142	METHOD AND DEVICE FOR DETERMINING THE SIZE OF A TRANSPARENT PARTICLE - A method is described for determining the size of a transparent particle (	09-18-2014
20140268143	METHOD AND DEVICE FOR DETERMINING CHARACTERISTIC PROPERTIES OF A TRANSPARENT PARTICLE - The invention relates to a method for determining the size d of a transparent particle, according to which method the particle is illuminated with light from a light source, a radiation detector measures a time-resolved intensity profile of light of the light source scattered by the particle, a reflection peak (	09-18-2014

Daniela Tropea, Cambridge, MA US

Patent application number	Description	Published
20090099077	TREATMENT OF RETT SYNDROME AND OTHER DISORDERS - The invention relates to methods for treatment of Rett Syndrome and other disorders of synaptic function and maturation using IGF1, (1-3)IGF-1, (1-3)IGF-1 analog(s) and/or related therapeutic molecules.	04-16-2009
20090297573	Identifying and Modulating Molecular Pathways that Mediate Nervous System Plasticity - The present invention provides methods for identifying genes and pathways involved in plasticity. The invention applies some of these methods to identify genes that are differentially regulated in at least a portion of the nervous system of an individual subjected to conditions known to result in altered nervous system plasticity, i.e., dark rearing (DR) or monocular deprivation (MD). The genes are targets for pharmacological agents that modify plasticity. The invention also identifies biological pathways that are enriched in genes that are differentially regulated under conditions known to result in altered nervous system plasticity. The present invention further provides methods and compositions for modifying plasticity in the nervous system of a subject. The invention includes a method for modifying plasticity in the nervous system of a subject comprising administering a plasticity-modifying agent to the subject, wherein the plasticity-enhancing agent modulates a gene or pathway that is differentially regulated in developmental conditions that alter nervous system plasticity (e.g., DR or MD). The methods and compositions may be administered to a subject suffering from damage to the nervous system or from a neuropsychiatric disorder in order to enhance recovery, reorganization, or function of the nervous system. The methods optionally include administering a proteolysis-enhancing agent to the subject.	12-03-2009
20120177630	TREATMENT OF RETT SYNDROME AND OTHER DISORDERS - The invention relates to methods for treatment of Rett Syndrome and other disorders of synaptic function and maturation using IGF1, (1-3)IGF-1, (1-3)IGF-1 analog(s) and/or related therapeutic molecules.	07-12-2012

Gregory Tropea, Berlin, CT US

Patent application number	Description	Published
20140252711	CLAMP - Embodiments generally relate to a clamp. In one embodiment, the clamp includes a bar, and a first jaw, movable along the bar and positioned on a first side of the bar. The clamp also includes a second jaw positioned on the bar on a second side of the bar, opposite the first side. The clamp also includes an actuator for moving the first jaw toward the second jaw for clamping one or more workpieces, and the actuator includes one or more drive plates operatively coupled to the bar when the first jaw is in a driving mode.	09-11-2014